| Product Code: ETC6661759 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Narcotic Drugs Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Narcotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Narcotic Drugs Market - Industry Life Cycle |
3.4 Canada Narcotic Drugs Market - Porter's Five Forces |
3.5 Canada Narcotic Drugs Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Canada Narcotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Canada Narcotic Drugs Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 Canada Narcotic Drugs Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.9 Canada Narcotic Drugs Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Canada Narcotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Canada |
4.2.2 Growing awareness and acceptance of medical cannabis as a treatment option |
4.2.3 Rising geriatric population requiring pain management |
4.2.4 Government initiatives to improve access to healthcare services |
4.2.5 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements for narcotic drugs |
4.3.2 Concerns over misuse and abuse of narcotic drugs |
4.3.3 Limited reimbursement policies for narcotic medications |
4.3.4 High cost associated with narcotic drugs |
4.3.5 Competition from alternative pain management therapies |
5 Canada Narcotic Drugs Market Trends |
6 Canada Narcotic Drugs Market, By Types |
6.1 Canada Narcotic Drugs Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Canada Narcotic Drugs Market Revenues & Volume, By Source, 2021- 2031F |
6.1.3 Canada Narcotic Drugs Market Revenues & Volume, By Natural, 2021- 2031F |
6.1.4 Canada Narcotic Drugs Market Revenues & Volume, By Semi-synthetic, 2021- 2031F |
6.1.5 Canada Narcotic Drugs Market Revenues & Volume, By Synthetic, 2021- 2031F |
6.2 Canada Narcotic Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Canada Narcotic Drugs Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.3 Canada Narcotic Drugs Market Revenues & Volume, By Cough, 2021- 2031F |
6.2.4 Canada Narcotic Drugs Market Revenues & Volume, By Diarrhea, 2021- 2031F |
6.2.5 Canada Narcotic Drugs Market Revenues & Volume, By Dysentery, 2021- 2031F |
6.2.6 Canada Narcotic Drugs Market Revenues & Volume, By Asthma, 2021- 2031F |
6.2.7 Canada Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Narcotic Drugs Market, By Drug |
6.3.1 Overview and Analysis |
6.3.2 Canada Narcotic Drugs Market Revenues & Volume, By Opium, 2021- 2031F |
6.3.3 Canada Narcotic Drugs Market Revenues & Volume, By Heroin, 2021- 2031F |
6.3.4 Canada Narcotic Drugs Market Revenues & Volume, By Codeine, 2021- 2031F |
6.3.5 Canada Narcotic Drugs Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.3.6 Canada Narcotic Drugs Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.3.7 Canada Narcotic Drugs Market Revenues & Volume, By Tramadol, 2021- 2031F |
6.3.8 Canada Narcotic Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.3.9 Canada Narcotic Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.3.10 Canada Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Narcotic Drugs Market, By Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Narcotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Canada Narcotic Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Canada Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada Narcotic Drugs Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Canada Narcotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Canada Narcotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Canada Narcotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Canada Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Narcotic Drugs Market Import-Export Trade Statistics |
7.1 Canada Narcotic Drugs Market Export to Major Countries |
7.2 Canada Narcotic Drugs Market Imports from Major Countries |
8 Canada Narcotic Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for narcotic drugs |
8.2 Patient satisfaction with pain management using narcotic drugs |
8.3 Average waiting time for patients to access narcotic drugs |
8.4 Percentage of healthcare providers trained in safe prescribing practices for narcotic drugs |
8.5 Number of reported adverse events related to narcotic drug use |
9 Canada Narcotic Drugs Market - Opportunity Assessment |
9.1 Canada Narcotic Drugs Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Canada Narcotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Canada Narcotic Drugs Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.4 Canada Narcotic Drugs Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.5 Canada Narcotic Drugs Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Canada Narcotic Drugs Market - Competitive Landscape |
10.1 Canada Narcotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Canada Narcotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here